Wagner Luis Nedel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wagner Luis Nedel has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Márcio Manozzo Boniatti
Department of Critical Care, Hospital de Clínicas de Porto Alegre - Porto Alegre (RS), Brazil
5 shared publications Caroline Deutschendorf
Infection Control Committee, Hospital de Clínicas de Porto Alegre, Porto Alegre 90410-000, Brazil
4 shared publicationsFernando da Silveira
Intensive Care Unit Grupo Hospitalar Conceição Porto Alegre Brazil
4 shared publicationsLuis Valmor Portela
Department of Biochemistry, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Porto Alegre 90035-003, Brazil
4 shared publications- Luis Valmor Portela
Laboratory of Neurotrauma and Biomarkers, Departamento de Bioquímica, Universidade Federal Do Rio Grande Do Sul, UFRGS, Anexo, Porto Alegre, Brazil
4 shared publications Afonso Kopczynski
Laboratory of Neurotrauma and Biomarkers, Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
3 shared publications
Latest Publications
- 3 August 2026
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 58 (1) , 164-171
Persistent inflammation, immunosuppression, and catabolism are associated with impaired lymphocytic mitochondrial metabolism during the early phase of sepsis. A single-center, prospective cohort study
Background: Lymphopenia and lymphocytic metabolism have been individually associated with poor prognosis in sepsis; however, the relationship between these factors remains poorly understood. We evaluated whether lymphocyte count and lymphocytic mitochondrial metabolism are associated with the development of persistent inflammation, immunosuppression, and catabolic syndrome (PICS). Methods: A prospective cohort study was conducted in four clinical-surgical intensive care units (ICUs). We included critically ill patients with sepsis requiring vasopressor support and assessed mitochondrial metabolism in isolated lymphocytes, including Complex I- and II-linked respiration, at sepsis diagnosis (day 1) and on day 3. Absolute lymphocyte counts and derived ratios, e.g., neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), were evaluated at the same time points. The primary outcome was the association between mitochondrial respiratory function and PICS. Secondary outcomes included associations between lymphocyte counts, derived biomarkers, and mitochondrial respiration. Results: We included 64 patients, 10 of whom developed PICS. At sepsis diagnosis, patients who did not develop PICS exhibited significantly higher Complex I and II-linked respiration compared with those who did (mean difference [MD] for Complex I: 115 pmol O₂ s–1 10–6 cells; 95% CI: 13–291; P = 0.01; MD for Complex II: 171 pmol O₂ s–1 10–6 cells; 95% CI: 31–397; P = 0.01). No significant differences were observed in the delta (day 3 minus day 1) mitochondrial respiration or lymphocyte count between the PICS and non-PICS groups. Additionally, lymphocyte counts and derived ratios showed no significant correlation with Complex I or II respiration, even when stratified by quartiles across time points. Conclusions: Our findings suggest that reduced mitochondrial Complex I- and II-linked respiration in lymphocytes at sepsis onset may be associated with the development of PICS. Nevertheless, this association remains exploratory and requires confirmation in larger, adequately powered studies.
- 3 August 2026
- Published by Termedia Sp. z.o.o. in Anaesthesiology Intensive Therapy
- Vol. 58 (1) , 164-171
Persistent inflammation, immunosuppression, and catabolism are associated with impaired lymphocytic mitochondrial metabolism during the early phase of sepsis. A single-center, prospective cohort study
Background: Lymphopenia and lymphocytic metabolism have been individually associated with poor prognosis in sepsis; however, the relationship between these factors remains poorly understood. We evaluated whether lymphocyte count and lymphocytic mitochondrial metabolism are associated with the development of persistent inflammation, immunosuppression, and catabolic syndrome (PICS). Methods: A prospective cohort study was conducted in four clinical-surgical intensive care units (ICUs). We included critically ill patients with sepsis requiring vasopressor support and assessed mitochondrial metabolism in isolated lymphocytes, including Complex I- and II-linked respiration, at sepsis diagnosis (day 1) and on day 3. Absolute lymphocyte counts and derived ratios, e.g., neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), were evaluated at the same time points. The primary outcome was the association between mitochondrial respiratory function and PICS. Secondary outcomes included associations between lymphocyte counts, derived biomarkers, and mitochondrial respiration. Results: We included 64 patients, 10 of whom developed PICS. At sepsis diagnosis, patients who did not develop PICS exhibited significantly higher Complex I and II-linked respiration compared with those who did (mean difference [MD] for Complex I: 115 pmol O₂ s–1 10–6 cells; 95% CI: 13–291; P = 0.01; MD for Complex II: 171 pmol O₂ s–1 10–6 cells; 95% CI: 31–397; P = 0.01). No significant differences were observed in the delta (day 3 minus day 1) mitochondrial respiration or lymphocyte count between the PICS and non-PICS groups. Additionally, lymphocyte counts and derived ratios showed no significant correlation with Complex I or II respiration, even when stratified by quartiles across time points. Conclusions: Our findings suggest that reduced mitochondrial Complex I- and II-linked respiration in lymphocytes at sepsis onset may be associated with the development of PICS. Nevertheless, this association remains exploratory and requires confirmation in larger, adequately powered studies.
- Open Access
- 9 June 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 15 (2) , 117211
High-density lipoprotein-cholesterol and triglyceride levels and their prognosis in critically ill septic patients
BACKGROUND Lipoproteins, particularly high-density lipoproteins (HDLs), have the ability to bind to lipopolysaccharides, the primary component of the extracellular membrane of gram-negative bacteria, as well as to lipoteichoic acid, an immunostimulant derived from gram-positive bacteria. Triglyceride (TG) levels are also indicators of acute inflammation. Altered levels of both are prevalent in sepsis, rendering them potential biomarkers that are cost-effective and readily applicable in clinical practice for monitoring these patients. It is crucial to compare the levels of these molecules with those of more traditional and costly biomarkers. AIM To evaluate the association between HDL and TG levels in the diagnosis of sepsis (HDL/TG day 1), as well as the association between the ratio of HDL and TG levels on days 3 and day 1 (HDL/TG ratio) and 28-day mortality in patients with sepsis. We also compared the serum levels of HDL and TG levels with traditional inflammatory markers used in the prognostic assessment of sepsis: Interleukin (IL)-1β, IL-6, and IL-10, measured serially in patients with sepsis. METHODS This was a prospective cohort study. Adult patients (> 18 years of age) admitted to the intensive care unit with sepsis and receiving vasopressors were included. We recorded the epidemiological and clinical characteristics, as well as the severity scores, at the time of sepsis diagnosis and on day 3 of sepsis management. We measured HDL 1, TG 1, IL-1β, IL-6, IL-10, and C-reactive protein (CRP) levels upon the diagnosis of sepsis and on day 3 and calculated the HDL and TG ratios. The main outcome was 28-days mortality. RESULTS Seventy-five patients had measurements on day 1 (male:female ratio 58%:42%), and 50 patients had measurements on day 3. Patients who died had lower HDL 1 [9 mg/dL (5-17) vs 18.5 mg/dL (8-31), P = 0.02] but did not have lower TG levels on day 1 [142 mg/dL (83-224) vs 148 mg/dL (97-196), P = 0.97]. Additionally, patients who succumbed exhibited a non-statistically significant increase in the HDL ratio [1.26 (1-1.79) vs 1.16 (1.01-1.39), P = 0.29] and a non-statistically significant increase in the TG ratio [1.16 (0.85-1.36) vs 1.02 (0.67-1.36), P = 0.69]. HDL levels on day 1 were negatively associated with IL-10 on day 1 (Pearson’s r = -0.37; P < 0.01) and with CRP on day 1 (Pearson’s r = -0.52; P < 0.01), but not with IL-6 (P = 0.19) or IL-1β (P = 0.62). TG 1 was positively associated with CRP on day 1 (Pearson’s r = 0.57, P < 0.01) but not with IL-6 (P = 0.21), IL-10 (P = 0.12), or IL-1β (P = 0.09). CONCLUSION HDL levels are a promising biomarker for the evaluation of patients with sepsis, and their levels correlate with traditional biomarkers in this field, such as CRP and IL-10. Further multicenter studies with larger cohorts should be conducted to confirm or refute this hypothesis.
- 9 June 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 15 (2) , 117211
Open AccessHigh-density lipoprotein-cholesterol and triglyceride levels and their prognosis in critically ill septic patients
BACKGROUND Lipoproteins, particularly high-density lipoproteins (HDLs), have the ability to bind to lipopolysaccharides, the primary component of the extracellular membrane of gram-negative bacteria, as well as to lipoteichoic acid, an immunostimulant derived from gram-positive bacteria. Triglyceride (TG) levels are also indicators of acute inflammation. Altered levels of both are prevalent in sepsis, rendering them potential biomarkers that are cost-effective and readily applicable in clinical practice for monitoring these patients. It is crucial to compare the levels of these molecules with those of more traditional and costly biomarkers. AIM To evaluate the association between HDL and TG levels in the diagnosis of sepsis (HDL/TG day 1), as well as the association between the ratio of HDL and TG levels on days 3 and day 1 (HDL/TG ratio) and 28-day mortality in patients with sepsis. We also compared the serum levels of HDL and TG levels with traditional inflammatory markers used in the prognostic assessment of sepsis: Interleukin (IL)-1β, IL-6, and IL-10, measured serially in patients with sepsis. METHODS This was a prospective cohort study. Adult patients (> 18 years of age) admitted to the intensive care unit with sepsis and receiving vasopressors were included. We recorded the epidemiological and clinical characteristics, as well as the severity scores, at the time of sepsis diagnosis and on day 3 of sepsis management. We measured HDL 1, TG 1, IL-1β, IL-6, IL-10, and C-reactive protein (CRP) levels upon the diagnosis of sepsis and on day 3 and calculated the HDL and TG ratios. The main outcome was 28-days mortality. RESULTS Seventy-five patients had measurements on day 1 (male:female ratio 58%:42%), and 50 patients had measurements on day 3. Patients who died had lower HDL 1 [9 mg/dL (5-17) vs 18.5 mg/dL (8-31), P = 0.02] but did not have lower TG levels on day 1 [142 mg/dL (83-224) vs 148 mg/dL (97-196), P = 0.97]. Additionally, patients who succumbed exhibited a non-statistically significant increase in the HDL ratio [1.26 (1-1.79) vs 1.16 (1.01-1.39), P = 0.29] and a non-statistically significant increase in the TG ratio [1.16 (0.85-1.36) vs 1.02 (0.67-1.36), P = 0.69]. HDL levels on day 1 were negatively associated with IL-10 on day 1 (Pearson’s r = -0.37; P < 0.01) and with CRP on day 1 (Pearson’s r = -0.52; P < 0.01), but not with IL-6 (P = 0.19) or IL-1β (P = 0.62). TG 1 was positively associated with CRP on day 1 (Pearson’s r = 0.57, P < 0.01) but not with IL-6 (P = 0.21), IL-10 (P = 0.12), or IL-1β (P = 0.09). CONCLUSION HDL levels are a promising biomarker for the evaluation of patients with sepsis, and their levels correlate with traditional biomarkers in this field, such as CRP and IL-10. Further multicenter studies with larger cohorts should be conducted to confirm or refute this hypothesis.
- Open Access
- 9 June 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 15 (2) , 116049
Letter to the Editor: Impact of the intensivist at the bedside - the case of rational use of benzodiazepines
The detrimental effects associated with prolonged benzodiazepine infusion have long been recognized, and precipitated a transformation in the management of sedation and analgesia in critically ill patients. This transformation emphasizes the need to reduce the continuous use of benzodiazepines. Achieving an appropriate sedo-analgesia target tailored to the patient’s context requires clinical staff to possess knowledge and considerable experience in this management. The study published in World Journal of Critical Care Medicine by Nestoiter et al exemplified this scenario. The authors identified an association between the continuous use of midazolam and the absence of a critical care team managing patients at the bedside. The use of continuous midazolam, as an indicator of good clinical practice, was associated with unfavorable clinical outcomes, such as increased days in coma and delirium. These results reinforce the fact that effective management of sedation and analgesia is a critical area where the fundamental role of the intensivist in the care of critically ill patients is evident. These findings should not be interpreted in isolation but rather within a set of organizational aspects that characterize a high-performing intensive care unit, such as an adequate patient-to-nurse ratio, the presence of an intensivist-led team, and the development of clinical protocols in sedation and analgesia management.
- 9 June 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 15 (2) , 116049
Open AccessLetter to the Editor: Impact of the intensivist at the bedside - the case of rational use of benzodiazepines
The detrimental effects associated with prolonged benzodiazepine infusion have long been recognized, and precipitated a transformation in the management of sedation and analgesia in critically ill patients. This transformation emphasizes the need to reduce the continuous use of benzodiazepines. Achieving an appropriate sedo-analgesia target tailored to the patient’s context requires clinical staff to possess knowledge and considerable experience in this management. The study published in World Journal of Critical Care Medicine by Nestoiter et al exemplified this scenario. The authors identified an association between the continuous use of midazolam and the absence of a critical care team managing patients at the bedside. The use of continuous midazolam, as an indicator of good clinical practice, was associated with unfavorable clinical outcomes, such as increased days in coma and delirium. These results reinforce the fact that effective management of sedation and analgesia is a critical area where the fundamental role of the intensivist in the care of critically ill patients is evident. These findings should not be interpreted in isolation but rather within a set of organizational aspects that characterize a high-performing intensive care unit, such as an adequate patient-to-nurse ratio, the presence of an intensivist-led team, and the development of clinical protocols in sedation and analgesia management.
- Open Access
- 22 April 2026
- Published by Queen's University Library in POCUS Journal
- Vol. 11 (01) , 37-44
Modified Venous Excess Ultrasound (mVExUS) in the Prediction of Ventilator Weaning Failure: a Cohort Study
Background: Ventilator weaning failure is a significant challenge in critically ill patients, and venous congestion has emerged as a potentially modifiable factor influencing weaning outcomes. This study aimed to investigate the association between venous congestion identified by the modified venous excess ultrasound (mVExUS) score and ventilator weaning failure in critically ill patients. Methods: We prospectively enrolled patients aged 18 years or older who had received mechanical ventilation (MV) for at least 48 hours. A mVExUS score, excluding the intrarenal component, and a lung point of care ultrasound (POCUS) assessment were performed before a spontaneous breathing trial (SBT). The primary outcome was weaning failure, defined as a failed SBT or the need for MV (invasive or non-invasive) within 72 hours. Results: Among 111 patients, 57 (51.4%) experienced ventilator weaning failure. Ventilator weaning failure occurred in 63.9% of patients with mVExUS scores of 2–3, compared to 45.3% with scores of 0–1 (p = 0.067). In adjusted analyses, mVExUS scores of 2–3 were independently associated with weaning failure (OR 2.756, p = 0.03). A post-hoc analysis combining mVExUS and lung POCUS scores showed a weaning failure incidence of 76.5% in patients with mVExUS scores of 2–3 and lung POCUS scores ≥7, compared to 34.1% in patients with mVExUS scores of 0–1 and lung POCUS scores <7 (p = 0.002). Conclusion: mVExUS scores of 2–3 are significantly associated with a higher risk of weaning failure and post-extubation respiratory failure. Combining VExUS and lung POCUS scores may enhance the assessment of weaning readiness in critically ill patients.
- 22 April 2026
- Published by Queen's University Library in POCUS Journal
- Vol. 11 (01) , 37-44
Open AccessModified Venous Excess Ultrasound (mVExUS) in the Prediction of Ventilator Weaning Failure: a Cohort Study
Background: Ventilator weaning failure is a significant challenge in critically ill patients, and venous congestion has emerged as a potentially modifiable factor influencing weaning outcomes. This study aimed to investigate the association between venous congestion identified by the modified venous excess ultrasound (mVExUS) score and ventilator weaning failure in critically ill patients. Methods: We prospectively enrolled patients aged 18 years or older who had received mechanical ventilation (MV) for at least 48 hours. A mVExUS score, excluding the intrarenal component, and a lung point of care ultrasound (POCUS) assessment were performed before a spontaneous breathing trial (SBT). The primary outcome was weaning failure, defined as a failed SBT or the need for MV (invasive or non-invasive) within 72 hours. Results: Among 111 patients, 57 (51.4%) experienced ventilator weaning failure. Ventilator weaning failure occurred in 63.9% of patients with mVExUS scores of 2–3, compared to 45.3% with scores of 0–1 (p = 0.067). In adjusted analyses, mVExUS scores of 2–3 were independently associated with weaning failure (OR 2.756, p = 0.03). A post-hoc analysis combining mVExUS and lung POCUS scores showed a weaning failure incidence of 76.5% in patients with mVExUS scores of 2–3 and lung POCUS scores ≥7, compared to 34.1% in patients with mVExUS scores of 0–1 and lung POCUS scores <7 (p = 0.002). Conclusion: mVExUS scores of 2–3 are significantly associated with a higher risk of weaning failure and post-extubation respiratory failure. Combining VExUS and lung POCUS scores may enhance the assessment of weaning readiness in critically ill patients.
- 13 April 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (4) , 853-854
Vasopressor weaning in septic shock: the missing piece in the 2026 guidelines
- 13 April 2026
- Published by Springer Nature in Intensive Care Medicine
- Vol. 52 (4) , 853-854
Vasopressor weaning in septic shock: the missing piece in the 2026 guidelines
- Open Access
- 3 March 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260273
Propofol infusion in critically ill patients is not associated with mitochondrial dysfunction or altered serum interleukin levels in the early sepsis response
INTRODUCTION The immune status of patients with sepsis changes dynamically across different stages, involving complex interactions among multiple immune cells and molecular mechanisms. A dysregulated balance between pro-inflammatory and anti-inflammatory responses can generate sepsis-induced immunosuppression.(1) A persistent immunosuppressive state is characterized by immune cell exhaustion, particularly in mononuclear cells, whereas late-stage mortality is frequently associated […] INTRODUCTION The immune status of patients with sepsis changes dynamically across different stages, involving complex interactions among multiple immune cells and molecular mechanisms. A dysregulated balance between pro-inflammatory and anti-inflammatory responses can generate sepsis-induced immunosuppression.(1) A persistent immunosuppressive state is characterized by immune cell exhaustion, particularly in mononuclear cells, whereas late-stage mortality is frequently associated […]
- 3 March 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260273
Open AccessPropofol infusion in critically ill patients is not associated with mitochondrial dysfunction or altered serum interleukin levels in the early sepsis response
INTRODUCTION The immune status of patients with sepsis changes dynamically across different stages, involving complex interactions among multiple immune cells and molecular mechanisms. A dysregulated balance between pro-inflammatory and anti-inflammatory responses can generate sepsis-induced immunosuppression.(1) A persistent immunosuppressive state is characterized by immune cell exhaustion, particularly in mononuclear cells, whereas late-stage mortality is frequently associated […] INTRODUCTION The immune status of patients with sepsis changes dynamically across different stages, involving complex interactions among multiple immune cells and molecular mechanisms. A dysregulated balance between pro-inflammatory and anti-inflammatory responses can generate sepsis-induced immunosuppression.(1) A persistent immunosuppressive state is characterized by immune cell exhaustion, particularly in mononuclear cells, whereas late-stage mortality is frequently associated […]
- 2 February 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260197
Effect of norepinephrine versus vasopressin weaning on incidence of hypotension in septic shock patients: a systematic review and meta-analysis
To evaluate the influence of weaning vasopressors - norepinephrine or vasopressin - on deleterious effects; the main objective was to evaluate the incidence of hypotension. We performed a systematic review and meta-analysis of 11 studies - 2 randomized controlled trials and 9 observational studies - involving 2,280 patients in whom norepinephrine (n = 1,254) or vasopressin (n = 1,026) was withdrawn first to compare the risk of hypotension and other adverse effects. Hypotension occurred in 33.4% (420/1,254) of patients in the Norepinephrine Group and in 52,4% (538/1,026) of patients in the Vasopressin Group. There was no difference between groups regarding the incidence of hypotension: OR 0.43 (95%CI 0.18 - 1.03). The subgroup analysis of observational studies suggests a lower incidence of hypotension when norepinephrine is weaned first (OR 0.26; 95%CI 0.13 - 0.53), with high heterogeneity between studies (I2 = 88%; p < 0.01). On the other hand, the subgroup of randomized controlled trials indicates a higher incidence of hypotension when norepinephrine is weaned first (OR 4.04; 95%CI 1.24 - 13.15; I2 = 65%, p = 0.09). The weaning strategy was not associated with other outcomes, including intensive care unit length of stay, hospital length of stay, time on vasopressors, arrhythmias, renal injury, or SOFA. No differences in hypotension incidence were observed when weaning was initiated with either norepinephrine or vasopressin. However, the high heterogeneity observed across studies warrants caution in drawing definitive conclusions.
- 2 February 2026
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 38, e20260197
Effect of norepinephrine versus vasopressin weaning on incidence of hypotension in septic shock patients: a systematic review and meta-analysis
To evaluate the influence of weaning vasopressors - norepinephrine or vasopressin - on deleterious effects; the main objective was to evaluate the incidence of hypotension. We performed a systematic review and meta-analysis of 11 studies - 2 randomized controlled trials and 9 observational studies - involving 2,280 patients in whom norepinephrine (n = 1,254) or vasopressin (n = 1,026) was withdrawn first to compare the risk of hypotension and other adverse effects. Hypotension occurred in 33.4% (420/1,254) of patients in the Norepinephrine Group and in 52,4% (538/1,026) of patients in the Vasopressin Group. There was no difference between groups regarding the incidence of hypotension: OR 0.43 (95%CI 0.18 - 1.03). The subgroup analysis of observational studies suggests a lower incidence of hypotension when norepinephrine is weaned first (OR 0.26; 95%CI 0.13 - 0.53), with high heterogeneity between studies (I2 = 88%; p < 0.01). On the other hand, the subgroup of randomized controlled trials indicates a higher incidence of hypotension when norepinephrine is weaned first (OR 4.04; 95%CI 1.24 - 13.15; I2 = 65%, p = 0.09). The weaning strategy was not associated with other outcomes, including intensive care unit length of stay, hospital length of stay, time on vasopressors, arrhythmias, renal injury, or SOFA. No differences in hypotension incidence were observed when weaning was initiated with either norepinephrine or vasopressin. However, the high heterogeneity observed across studies warrants caution in drawing definitive conclusions.
- Open Access
- 20 November 2025
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 76 (1) , 844712
Association between troponin and NT-proBNP levels, cytokines, and clinical outcomes in early sepsis response: a cohort study
- 20 November 2025
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 76 (1) , 844712
Open AccessAssociation between troponin and NT-proBNP levels, cytokines, and clinical outcomes in early sepsis response: a cohort study
- Open Access
- 17 June 2025
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 37, e20250098
Peer review for medical journals: why and how?
WHY IS PEER REVIEW SO IMPORTANT? Peer review is fundamental to scientific knowledge construction, ensuring the quality and reliability of research in an era of rapid information dissemination and limited content oversight. This became particularly evident during the COVID-19 pandemic, when the accelerated publication of preprints on platforms such as medRxiv and bioRxiv, while facilitating […] WHY IS PEER REVIEW SO IMPORTANT? Peer review is fundamental to scientific knowledge construction, ensuring the quality and reliability of research in an era of rapid information dissemination and limited content oversight. This became particularly evident during the COVID-19 pandemic, when the accelerated publication of preprints on platforms such as medRxiv and bioRxiv, while facilitating […]
- 17 June 2025
- Published by Associação de Medicina Intensiva Brasileira in Critical Care Science
- Vol. 37, e20250098
Open AccessPeer review for medical journals: why and how?
WHY IS PEER REVIEW SO IMPORTANT? Peer review is fundamental to scientific knowledge construction, ensuring the quality and reliability of research in an era of rapid information dissemination and limited content oversight. This became particularly evident during the COVID-19 pandemic, when the accelerated publication of preprints on platforms such as medRxiv and bioRxiv, while facilitating […] WHY IS PEER REVIEW SO IMPORTANT? Peer review is fundamental to scientific knowledge construction, ensuring the quality and reliability of research in an era of rapid information dissemination and limited content oversight. This became particularly evident during the COVID-19 pandemic, when the accelerated publication of preprints on platforms such as medRxiv and bioRxiv, while facilitating […]
- Open Access
- 9 June 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 14 (2) , 98791
Why should lymphocytes immune profile matter in sepsis?
The global incidence of critical illness has been steadily increasing, resulting in higher mortality rates thereby presenting substantial challenges for clinical management. Among these conditions, sepsis stands out as the leading cause of critical illness, underscoring the urgent need for continued research to enhance patient care and deepen our understanding of its complex pathophysiology. Lymphocytes play a pivotal role in both innate and adaptive immune responses, acting as key regulators of the balance between pro-inflammatory and anti-inflammatory processes to preserve immune homeostasis. In the context of sepsis, an impaired immunity has been associated with disrupted lymphocytic metabolic activity, persistent pro-inflammatory state, and subsequent immunosuppression. These disruptions not only impair pathogen clearance but also predispose patients to secondary infections and hinder recovery, highlighting the importance of targeting lymphocyte dysfunction in sepsis management. Moreover, studies have identified absolute lymphocyte counts and derived parameters as promising clinical biomarkers for prognostic assessment and therapeutic decision-making. In particular, neutrophil-to-lymphocyte ratio, and lymphopenia have gained recognition in the literature as a critical prognostic markers and therapeutic target in the management of sepsis. This review aims to elucidate the multifaceted role of lymphocytes in pathophysiology, with a focus on recent advancements in their use as biomarkers and key findings in this evolving field.
- 9 June 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Critical Care Medicine
- Vol. 14 (2) , 98791
Open AccessWhy should lymphocytes immune profile matter in sepsis?
The global incidence of critical illness has been steadily increasing, resulting in higher mortality rates thereby presenting substantial challenges for clinical management. Among these conditions, sepsis stands out as the leading cause of critical illness, underscoring the urgent need for continued research to enhance patient care and deepen our understanding of its complex pathophysiology. Lymphocytes play a pivotal role in both innate and adaptive immune responses, acting as key regulators of the balance between pro-inflammatory and anti-inflammatory processes to preserve immune homeostasis. In the context of sepsis, an impaired immunity has been associated with disrupted lymphocytic metabolic activity, persistent pro-inflammatory state, and subsequent immunosuppression. These disruptions not only impair pathogen clearance but also predispose patients to secondary infections and hinder recovery, highlighting the importance of targeting lymphocyte dysfunction in sepsis management. Moreover, studies have identified absolute lymphocyte counts and derived parameters as promising clinical biomarkers for prognostic assessment and therapeutic decision-making. In particular, neutrophil-to-lymphocyte ratio, and lymphopenia have gained recognition in the literature as a critical prognostic markers and therapeutic target in the management of sepsis. This review aims to elucidate the multifaceted role of lymphocytes in pathophysiology, with a focus on recent advancements in their use as biomarkers and key findings in this evolving field.